The efficacy of Zonisamide for BPSD in Dementia with Lewy bodies. A randomized, single-blind, placebo-control trial.
Phase 2
- Conditions
- Dementia with Lewy bodies
- Registration Number
- JPRN-UMIN000010631
- Lead Sponsor
- ational Center for Geriatrics and Gerontology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patient with non DLB. 2 No focal lesion exists in brain MRI. 3 Has current serious illness, psychiatric problem or drug abuse. 4 Those who have used Zonisamide over before. 5 Those who have joined any clinical trial within 3 month. 6 Those who have received medications that affected the central nervous system within 4 weeks. 7 Dose of chronic medications that affect CNS should be stable for at least 4 weeks before Visit0. 8 Those who are judged inadequate by their doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method europsychiatric Inventory
- Secondary Outcome Measures
Name Time Method Mini Mental State Examination Neuropsychiatric Inventory Brief Questionnare Form Unified Parkinsons Disease Rating Scale